Clinical Trial Update: Dexmedetomidine Supplemented Analgesia in Patients at High-risk of Obstructive Sleep Apnea [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating dexmedetomidine supplemented analgesia in high-risk obstructive sleep apnea patients; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Peking University First Hospital | Conditions: Obstructive Sleep Apnea, Analgesia | Phase 4 | Status: COMPLETED